SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-030209
Filing Date
2014-04-25
Accepted
2014-04-25 07:57:30
Documents
7
Period of Report
2014-04-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-10973_18k.htm 8-K 26785
2 EX-99.1 a14-10973_1ex99d1.htm EX-99.1 220489
3 GRAPHIC g109731mm03i001.jpg GRAPHIC 1814
4 GRAPHIC g109731mm05i001.jpg GRAPHIC 1885
5 GRAPHIC g109731mm01i001.jpg GRAPHIC 1786
6 GRAPHIC g109731mm07i001.jpg GRAPHIC 1786
7 GRAPHIC g109731mm09i001.jpg GRAPHIC 1786
  Complete submission text file 0001104659-14-030209.txt   261616
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 14783052
SIC: 2834 Pharmaceutical Preparations